Matrix metalloproteinase‐9 expression in the nuclear compartment of neurons and glial cells in aging and stroke

Matrix metalloproteinases (MMPs) are well‐recognized denominators for extracellular matrix remodeling in the pathology of both ischemic and hemorrhagic strokes. Recent data on non‐nervous system tissue showed intracellular and even intranuclear localizations for different MMPs, and together with this, a plethora of new functions have been proposed for these intracellular active enzymes, but are mostly related to apoptosis induction and malign transformation. In neurons and glial cells, on human tissue, animal models and cell cultures, different active MMPs have been also proven to be located in the intra‐cytoplasmic or intra‐nuclear compartments, with no clear‐cut function. In the present study we show for the first time on human tissue the nuclear expression of MMP‐9, mainly in neurons and to a lesser extent in astrocytes. We have studied ischemic and hemorrhagic stroke patients, as well as aged control patients. Age and ischemic suffering seemed to be the best predictors for an elevated MMP‐9 nuclear expression, and there was no evidence of a clear‐cut extracellular proteolytic activity for this compartment, as revealed by intact vascular basement membranes and assessment of vascular densities. More, the majority of the cells expressing MMP‐9 in the nuclear compartment also co‐expressed activated‐caspase 3, indicating a possible link between nuclear MMP‐9 localization and apoptosis in neuronal and glial cells following an ischemic or hemorrhagic event. These results, besides showing for the first time the nuclear localization of MMP‐9 on a large series of human stroke and aged brain tissues, raise new questions regarding the unknown spectrum of the functions MMPs in human CNS pathology.